{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:43:04Z","timestamp":1772761384063,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1029148"],"award-info":[{"award-number":["1029148"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.placenta.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:33:50Z","timestamp":1434688430000},"page":"926-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of activin A signalling in a mouse model of pre-eclampsia"],"prefix":"10.1016","volume":"36","author":[{"given":"R.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gurusinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Leaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ciayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.F.","family":"Kelso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.W.","family":"Hearn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2015.06.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldg015","article-title":"Global burden of maternal death and disability","volume":"67","author":"AbouZahr","year":"2003","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.placenta.2015.06.004_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/AOG.0b013e3182a06f4e","article-title":"Maternal morbidity and risk of death at delivery hospitalization","volume":"122","author":"Campbell","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.placenta.2015.06.004_bib3","first-page":"533","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"MacKay","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.placenta.2015.06.004_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/GCO.0b013e3283404e89","article-title":"Maternal mortality: new strategies for measurement and prevention","volume":"22","author":"Main","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.placenta.2015.06.004_bib5","first-page":"1","article-title":"Pregnancy-related mortality surveillance\u2013United States, 1991\u20131999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.07.021","article-title":"Activin and NADPH-oxidase in preeclampsia: insights from in\u00a0vitro and murine studies","volume":"212","author":"Lim","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.placenta.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/eje.0.1450225","article-title":"Expression and secretion of activin A: possible physiological and clinical implications","volume":"145","author":"Luisi","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.placenta.2015.06.004_bib8","first-page":"3328","article-title":"Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy","volume":"81","author":"Muttukrishna","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9061","key":"10.1016\/j.placenta.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(96)09264-1","article-title":"Activin A and inhibin A as possible endocrine markers for pre-eclampsia","volume":"349","author":"Muttukrishna","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1081\/PRG-120016794","article-title":"Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin","volume":"22","author":"Bersinger","year":"2003","journal-title":"Hypertens Pregnancy"},{"issue":"6659","key":"10.1016\/j.placenta.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.placenta.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"21129","DOI":"10.1074\/jbc.M302015200","article-title":"Identification of a functional binding site for activin on the type I receptor ALK4","volume":"278","author":"Harrison","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.placenta.2015.06.004_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Commun Signal"},{"issue":"12","key":"10.1016\/j.placenta.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1210\/mend.14.12.0570","article-title":"Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling","volume":"14","author":"Zhou","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.placenta.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1196\/annals.1315.023","article-title":"Activins and inhibins and their signaling","volume":"1038","author":"Vale","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.placenta.2015.06.004_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nrd1580","article-title":"Development of TGF-beta signalling inhibitors for cancer therapy","volume":"3","author":"Yingling","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"18","key":"10.1016\/j.placenta.2015.06.004_bib17","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1016\/j.bmcl.2010.12.120","article-title":"2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-\u03b21 and activin A signalling","volume":"21","author":"Ciayadi","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10.1016\/j.placenta.2015.06.004_bib18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1158\/1535-7163.MCT-13-0903","article-title":"EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis","volume":"13","author":"Son","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/radiol.09090670","article-title":"IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model","volume":"255","author":"Kim","year":"2010","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.placenta.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/jm0509905","article-title":"Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor","volume":"49","author":"Gellibert","year":"2006","journal-title":"J\u00a0Med Chem"},{"issue":"19","key":"10.1016\/j.placenta.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1021\/jm0205705","article-title":"Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain","volume":"46","author":"Sawyer","year":"2003","journal-title":"J\u00a0Med Chem"},{"issue":"2","key":"10.1016\/j.placenta.2015.06.004_bib22","first-page":"267","article-title":"The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis","volume":"76","author":"Kozian","year":"1997","journal-title":"Lab Invest"},{"issue":"8","key":"10.1016\/j.placenta.2015.06.004_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1681\/ASN.V1281685","article-title":"Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats","volume":"12","author":"Maeshima","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.placenta.2015.06.004_bib24","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.bbagen.2012.08.025","article-title":"The TGF\u03b2 superfamily in stem cell biology and early mammalian embryonic development","volume":"1830","author":"Beyer","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.placenta.2015.06.004_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2011.06.030","article-title":"New insights into the mechanisms of activin action and inhibition","volume":"359","author":"Walton","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ydbio.2008.03.045","article-title":"TGF-beta type I receptor Alk5 regulates tooth initiation and mandible patterning in a type II receptor-independent manner","volume":"320","author":"Zhao","year":"2008","journal-title":"Dev Biol"},{"issue":"4","key":"10.1016\/j.placenta.2015.06.004_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1095\/biolreprod.112.106542","article-title":"Transforming growth factor-beta 1 (TGF-B1) liberation from its latent complex during embryo implantation and its regulation by estradiol in mouse","volume":"89","author":"Maurya","year":"2013","journal-title":"Biol Reprod"},{"issue":"3","key":"10.1016\/j.placenta.2015.06.004_bib28","first-page":"786","article-title":"Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast","volume":"76","author":"Horowitz","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0897.1998.tb00388.x","article-title":"Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy at the human maternal-fetal interface","volume":"40","author":"Ando","year":"1998","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.placenta.2015.06.004_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev Cell"},{"issue":"1","key":"10.1016\/j.placenta.2015.06.004_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.preghy.2013.09.002","article-title":"The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia","volume":"4","author":"Gurusinghe","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"7","key":"10.1016\/j.placenta.2015.06.004_bib32","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.fertnstert.2008.12.125","article-title":"Evaluation of endometrial activin A secretion for prediction of pregnancy after intrauterine insemination","volume":"93","author":"Florio","year":"2010","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.placenta.2015.06.004_bib33","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1210\/jcem.87.8.8880","article-title":"Activin A promotes human endometrial stromal cell decidualization in\u00a0vitro","volume":"87","author":"Jones","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6520","key":"10.1016\/j.placenta.2015.06.004_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/374356a0","article-title":"Different phenotypes for mice deficient in either activins or activin receptor type II","volume":"374","author":"Matzuk","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.placenta.2015.06.004_bib35","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1242\/dev.120.12.3621","article-title":"Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins","volume":"120","author":"Feijen","year":"1994","journal-title":"Development"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400415009546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400415009546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:52:04Z","timestamp":1758909124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400415009546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0143400415009546"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2015.06.004","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of activin A signalling in a mouse model of pre-eclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}